drugset / Trial / NCT01374698

Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.

NCT01374698 ↗

Phase 4 Completed 100 enrolled University of Roma La Sapienza
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective, randomized study conducted in patients undergoing coronary revascularization procedures (PCI) through angioplasty. All patients who meet the eligibility criteria will be randomized to receive, before the procedure, an oral aspirin reload (325 mg) and to be re-evaluated at 60 minutes, 120 minutes, 6 hours, 48 hours, 5 and 30 day, 3 and 6 months.

Timeline

Start
2011-01
Primary completion
2011-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 325 mg Oral